Drafted protocol for clinical use. Researched the activation of several transcriptional regulators via irradiation. Drafted clinical protocol for inhibiting angioplasty restenosis, presently in Phase III clinical trials. Operated three-acre greenhouse and laboratory facility under sharing arrangement. Responsibilities included raising seed-capital, marketing and management of all business transactions.
Company presently exists under new ownership.
Assisted team of researchers develop the first pharmaceutical agent to cure Hairy-Cell Leukemia. Developed diagnostic kits detecting several autoimmune diseases. Represented company in technical capacity in field. Managed Automated Department and database repository. Initiated and developed five-week program with Carnegie Mellon University Office of Development and Carnegie Mellon University Enterprise Institute to promote entrepreneurship and to assist start up firms in capitalizing and protecting intellectual property.